Back
Ligand Pharmaceuticals Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer16.jpg)
Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector
Click here for the details.
Sell
48
LGND
Ligand Pharmaceuticals
Last Price:
82.65
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer12.jpg)
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion SuperprojectLigand Pharmaceuticals Price Quote
$82.65
-0.05 (-2.52%)
(Updated: July 4, 2024 at 4:15 AM ET)
Ligand Pharmaceuticals Key Stats
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Day range:
$82.22 - $84.90
52-week range:
$49.24 - $94.57
Dividend yield:
0%
P/E ratio:
28.13
P/S ratio:
12.39
P/B ratio:
1.84%
Volume:
63.1K
Avg. volume:
121.8K
1-year change:
13.8%
Market cap:
$1.5B
Revenue:
$131.3M
EPS:
$5.32
How Much Does Ligand Pharmaceuticals Make?
-
How Much Are Ligand Pharmaceuticals's Sales Annually?
LGND Revenues are $131.3M -
How Much Profit Does Ligand Pharmaceuticals's Make A Year?
LGND net income is $52.2M
Is Ligand Pharmaceuticals Growing As A Company?
-
What Is Ligand Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.3% -
What Is Ligand Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 1.04%
Ligand Pharmaceuticals Stock Price Performance
-
Did Ligand Pharmaceuticals Stock Go Up Last Month?
Ligand Pharmaceuticals share price went down by -5.93% last month -
Did LGND's Share Price Rise Over The Last Year?
LGND share price rose by 13.8% over the past 1 year
What Is Ligand Pharmaceuticals 52-Week High & Low?
-
What Is Ligand Pharmaceuticals’s 52-Week High Share Price?
Ligand Pharmaceuticals has traded as high as $94.57 over the past 52 weeks -
What Is Ligand Pharmaceuticals’s 52-Week Low Share Price?
Ligand Pharmaceuticals has traded as low as $49.24 over the past 52 weeks
Ligand Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ligand Pharmaceuticals?
-
How Much Debt Does Ligand Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Ligand Pharmaceuticals Have?
Cash and short term investments quarterly total is $310.6M -
What Is Ligand Pharmaceuticals’s Book Value Per Share?
Book value per share is 45.00
Is Ligand Pharmaceuticals Cash Flow Positive?
-
What Is LGND Cash Flow From Operations?
Cash flow from operations (TTM) is $34.4M -
What Is Ligand Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$47M -
What Is Ligand Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$26M
Ligand Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
LGND return on invested capital is 13.52% -
What Is Ligand Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 11.93% -
What Is LGND Return On Equity?
ROE is a measure of profitability and is 13.82%
Ligand Pharmaceuticals Earnings Date & Stock Price
-
What Is Ligand Pharmaceuticals's Stock Price Today?
A single share of LGND can be purchased today for 82.70 -
What Is Ligand Pharmaceuticals’s Stock Symbol?
Ligand Pharmaceuticals trades on the nasdaq under the ticker symbol: LGND -
When Is Ligand Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Ligand Pharmaceuticals is scheduled on August 8, 2024 -
When Is LGND's next ex-dividend date?
Ligand Pharmaceuticals's next ex-dividend date is March 11, 2016 -
How To Buy Ligand Pharmaceuticals Stock?
You can buy Ligand Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ligand Pharmaceuticals Competitors
-
Who Are Ligand Pharmaceuticals's Competitors?
Below is a list of companies who compete with Ligand Pharmaceuticals or are related in some way:
Ligand Pharmaceuticals Dividend Yield
Data Unavailable
Ligand Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 103.86% | 43.89% |
Revenue: | -29.56% | 10.94% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 116.80 |
Upside from Last Price: | 41.23% |